Belotero® Intense provides optimal filling capacity and is the ideal filler for correcting fine to deep lines. Belotero® Intense integrates seamlessly into the skin. The excellent tissue integration minimises skin irregularities and provides natural looking results. it can be used to create a volumising effect to nasolabial folds, marionette lines, lip contours, lip volume, oral commissures and Cupid’s bow.
The pack consists of:
- 1 x 1ml syringe
- 2 x 27G needles
- 25,5 mg/ml Cross-Linked Sodium Hyaluronate
Benefits of Belotero® Intense:
- Correct fine to deep lines
- Excellent tissue integration
- Create volume
- Optimal filling capacity
How long does the result last for?
The duration depends on the individual’s lifestyle, age and skin type
Who should not use BELOTERO BALANCE?
BELOTERO BALANCE should not be used in patients with a history of or presence of multiple or severe allergies, including those with a history of anaphylaxis. BELOTERO BALANCE should not be used in patients with allergies to gram-positive bacterial proteins..
What is the most important information I should know about BELOTERO BALANCE?
Introduction of BELOTERO BALANCE into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft tissue fillers, for example inject the product slowly and apply the least amount of pressure necessary. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms, including changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and possibly evaluation by an appropriate health care practitioner specialist should an intravascular injection occur.
THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)